Skip to main content

Hyperbilirubinemia

Tracking # 20-1298980

$40.00

There are no ratings for this course

Learn more
Educator EMEDED INC.
CE Broker Reporting Reported automatically
Method Computer-Based Training

Course overview

Educational Objectives: At the end of this course, attendees will be able to: 1. Describe the new AAP clinical practice Guideline for newborn infants 35 or more weeks of gestation. 2. Discuss Prevention of hyperbilirubinemia 3. Explain assessment and monitoring for hyperbilirubinemia. 4. Choose the best treatment (Phototherapy vs exchange transfusion). 5. Interpret the complications of neonatal hyperbilirubinemia

Subject areas

This course counts toward the state boards and subject areas below.

Florida Board of Medicine

Medical Doctor

1h General (AMA Category I)

Georgia Composite Medical Board - Physicians & Telemedicine

Physician

1h General CME

Louisiana State Board of Medical Examiners - Physicians & Surgeons

Physician & Surgeon

1h Category I CME

Michigan Board of Medicine

Medical Doctor

1h Category 1 Hours

Mississippi State Board of Medical Licensure

Medical Doctor

1h AMA Category I

New Hampshire Board of Medicine

Physician

1h Category 1 Hours

New Mexico Medical Board

Medical Doctor

1h General CME - AMA/AOA Category 1

Oklahoma Board of Medical Licensure and Supervision - Medical Doctors

Medical Doctor

1h Category I CME

State Medical Board of Ohio

Doctor of Medicine

1h AMA Category I

Tennessee Board of Medical Examiners

Medical Doctor

1h AMA Category I CME

Texas Medical Board - Physicians

Physician

1h Formal Category 1 or 1A Hours

Wisconsin Medical Examining Board

Physician

1h Category I CME

Disclosure statements

eMedEd ensures balance, independence, objectivity, and scientific rigor in all our educational activities. In accordance with this policy, eMedEd identifies conflicts of interest with its instructors, planners, content managers, and other individuals who can control an activity's content. 


All faculty, planners, and/or content managers have nothing to disclose, nor do they have any vested interests or affiliations.